It is estimated that approximately 70-80% of adult ITP patients have anti-GPIIb/IIIa antibodies, and the other 20-40% of patients have anti-GPIbα antibodies. The gene discussed is GP1BA; the disease is autoimmune thrombocytopenic purpura.